Regeneron/Sanofi to cut price of heart drug in Express Scripts deal

(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA will cut the net price of their expensive cholesterol drug for Express Scripts Holdings Co customers in exchange for greater patient access, with some savings to be shared with consumers, the companies said on Tuesday.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *